Published in Respiratory Therapeutics Week, January 30th, 2012
"We randomly assigned 28 patients who were on continuous home O-2 for COPD to use each of 3 O-2 delivery systems...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.